Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ItalyBack to Italy

Clinical trials in Rimini – page 8

88 clinical trials in Rimini, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Rimini at a glance
88
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

88 trials in Rimini

Open in trial search

Hormone receptor positive breast cancer+1

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:F. Hoffmann-La Roche AG

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Alemtuzumab
  • Sponsor:St. Anna Childrens Cancer Research Institute GmbH

Anaplastic large cell lymphoma T- and null-cell types+2

Not recruiting
InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Romidepsin
  • Sponsor:Fondazione Italiana Linfomi Ets

Mantle cell lymphoma stage II+2

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum Der Universitat Munchen AöR

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Rimini

What the registry says about research in the country

01 Oncology - Lung Cancer

Studies focusing on non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), evaluating innovative treatment approaches including targeted therapies and immunotherapy combinations.

  • MET deregulation treatments
  • Post-surgery immunotherapy
  • Chemo-immunotherapy protocols

Clinical trials investigating both early-stage and metastatic disease management strategies.

02 Hematologic Malignancies

Comprehensive research into blood cancers, including acute myeloid leukemia, multiple myeloma, and various lymphomas.

  • Novel drug combinations
  • Maintenance therapies
  • Targeted treatments

Focus on improving treatment outcomes through innovative therapeutic approaches and personalized medicine.

03 Breast Cancer Research

Studies examining treatments for various breast cancer subtypes, particularly ER-positive/HER2-negative and triple-negative breast cancer.

  • Hormone therapy innovations
  • Immunotherapy combinations
  • Early-stage interventions

Investigating new therapeutic strategies for both early-stage and metastatic disease.

Back to ItalyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.